JRCT ID: jRCT2080224624
Registered date:02/04/2019
Basic Information
Recruitment status | completed |
---|---|
Health condition(s) or Problem(s) studied | |
Date of first enrollment | 26/03/2019 |
Target sample size | 30 |
Countries of recruitment | Japan,North America,Europe |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : INN of investigational material : Oteseconazole Therapeutic category code : 629 Other chemotherapeutics Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : --- Other Dosage and Administration for Investigational material : |
Outcome(s)
Primary Outcome | efficacy |
---|---|
Secondary Outcome | other |
Key inclusion & exclusion criteria
Age minimum | >= 12age old |
---|---|
Age maximum | Not applicable |
Gender | Female |
Include criteria | |
Exclude criteria |
Related Information
Primary Sponsor | Mycovia Pharmaceuticals, Inc (ICCC: IQVIA Services Japan K.K.) |
---|---|
Secondary Sponsor | - |
Source(s) of Monetary Support | - |
Secondary ID(s) | NCT03562156,JapicCTI-194696 |
Contact
Public contact | |
Name | |
Address | |
Telephone | - |
Mycovia_CL011_JP_Registry@quintiles.com | |
Affiliation | |
Scientific contact | |
Name | |
Address | |
Telephone | - |
Mycovia_CL011_JP_Registry@quintiles.com | |
Affiliation |